Online citations, reference lists, and bibliographies.
← Back to Search

Blepharospasm With Basal Ganglia Lesions.

J. Jankovic
Published 1986 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
To the Editor. —In 1983, we were the first to suggest that blepharospasm may be associated with rostral brainstem-diencephalic lesions, 1 and, therefore, we found the report by Keane and Young 2 of a 31-year-old man with blepharospasm as a consequence of ischemia of the striatum to be extremely interesting. After our original series of six patients, we and others observed additional patients with an identifiable lesion in this area (Table). 3-8 One such patient was of particular interest. Report of a Case. —A 50-year-old man had had progressive parkinsonian symptoms for eight years. The most disabling findings were a coarse rest and action tremor, bradykinesia, and painful rigidity, more severe on the left side. Because the tremor was disabling and did not respond to anticholinergic or dopaminergic therapy, the patient underwent a right-sided thalamotomy in the nucleus ventralis intermedius on Jan 28, 1985, and a left-sided thalamotomy six months
This paper references



This paper is referenced by
10.1176/AJP.155.4.555
Higher prevalence of obsessive-compulsive symptoms in patients with blepharospasm than in patients with hemifacial spasm.
A. Broocks (1998)
A case of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) patient presenting with chorea
E. J. Chung (2012)
10.1016/0013-4694(93)90086-B
Auditory brain-stem responses in blepharospasm.
D. Creel (1993)
10.1017/S0317167100039184
Symptomatic dystonias associated with structural brain lesions: report of 16 cases.
V. Kostić (1996)
10.1054/BJOM.1999.0238
Botulinum toxin: new treatment for temporomandibular disorders.
B. Freund (2000)
10.1136/jnnp.55.10.925
Lesions of basal ganglia due to disulfiram neurotoxicity.
D. Laplane (1992)
10.1111/j.1468-1331.1995.tb00173.x
Movement disorders in ischemic stroke: clinical study of 22 patients
L. D'Olhaberriague (1995)
10.1046/j.1526-4610.2000.00033.x
Treatment of Chronic Cervical‐Associated Headache With Botulinum Toxin A: A Pilot Study
B. Freund (2000)
10.1007/BF02333996
Beneficial effect of botulinum A toxin in blepharospasm: 16 months' experience with 16 cases
S. Maurri (2006)
10.1016/j.jns.2016.11.053
Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment
Sanjay Pandey (2017)
10.1002/MDS.870130347
Blepharospasm associated with bilateral infarcts confined to the thalamus: Case report
M. Miranda (1998)
10.1016/S0035-3787(04)71031-0
Athétose ou dystonie
F. Turny (2004)
10.1212/WNL.37.4.616
Botulinum A toxin for cranial‐cervical dystonia
J. Jankovic (1987)
10.1002/1531-8257(200101)16:1<164::AID-MDS1030>3.0.CO;2-X
Clinical and genetic studies on familial parkinsonism: The first report on a parkin gene mutation in a Taiwanese family
C. S. Lu (2001)
10.1016/0736-4679(90)90452-2
Blepharospasm-oromandibular dystonia associated with a left cerebellopontine angle meningioma.
J. Persing (1990)
10.1056/NEJM198602063140607
What is it? Case 5, 1986.
L. Faber (1986)
10.1016/S0161-6420(88)32977-5
Long-term results and complications of botulinum A toxin in the treatment of blepharospasm.
J. Dutton (1988)
Effect of injection of botulinum toxin on lateral pterygoid muscle used together with the arthroscopy in patients with anterior disk displacement of the temporomandibular joint.
A. Arinci (2009)
10.1016/B978-0-12-089445-1.50024-2
20 – Clinical aspects and treatment of cranial movement disorders
J. Jankovic (1990)
10.1017/S0317167100052896
Meige syndrome secondary to basal ganglia injury: a potential cause of acute respiratory distress.
C. Kirton (2001)
10.1080/01658107.2018.1542009
Efficacy and Safety of Long-Term Therapy with Type A Botulinum Toxin in Patients with Blepharospasm
F. Vivancos-Matellano (2019)
10.1016/j.parkreldis.2020.06.034
Basal ganglia and cerebellar circuits have distinct roles in blepharospasm.
A. Glickman (2020)
Demographic and clinical features of patients with blepharospasm in southern Taiwan: a university hospital-based study.
W. Hwang (2012)
10.1016/S0002-9394(14)77067-9
Ocular movements in essential blepharospasm.
J. Demer (1990)
10.1016/B978-0-444-52014-2.00038-0
Nonprimary dystonias.
D. Dressler (2011)
10.1002/MDS.870020303
Blepharospasm and autoimmune diseases
J. Jankovic (1987)
10.1016/B978-0-444-52014-2.00037-9
Adult-onset dystonia.
M. Evatt (2011)
10.1002/MDS.870020208
Blepharospasm accompanying hypoxic encephalopathy
P. Palakurthy (1987)
10.3390/toxins12040269
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
Travis Hassell (2020)
10.1007/s004150050347
Idiopathic blepharospasm does not lead to a parkinsonian syndrome: results of a questionnaire-based follow-up study
N. Soonawala (1999)
10.1212/WNL.42.3.597
Linkage studies in Charcot‐Marie‐Tooth disease type 2
L. Loprest (1992)
10.1002/MDS.870040411
Life‐threatening cranial dystonia following trihexyphenidyl withdrawal
S. Giménez-Roldán (1989)
See more
Semantic Scholar Logo Some data provided by SemanticScholar